What is the blood concentration of mitotane and what are its functions and effects?

Plasma concentrations of Mitotane (Mitotane) can vary depending on the patient's specific circumstances and should therefore be monitored and adjusted based on individualized treatment regimens. Generally speaking, maintaining blood drug concentrations within the therapeutic range can ensure the efficacy and safety of the drug. Mitotane may cause some side effects, such as nausea, vomiting, loss of appetite, abnormal liver function, etc. Therefore, during treatment with mitotane, patients need to regularly monitor blood and liver function and work closely with their doctors to promptly report any symptoms of discomfort.

In terms of action and efficacy, mitotane mainly treats pheochromocytoma by affecting adrenocortical function. Specifically, it inhibits the production and release of hormones from the adrenal cortex, thereby reducing pheochromocytoma growth and activity. The main goals of using mitotane are to reduce the size of pheochromocytoma, relieve associated symptoms, and prolong patient survival. However, mitotane is not the treatment of choice for all patients, and the appropriateness of this drug should be determined by the physician based on the patient's specific circumstances.

The original drug of mitotane has been launched in China, but it has only been on the market for a short time, its purchase is very difficult, and it is not included in medical insurance. Mitotane marketed overseas The original drug has European and Turkish versions, specificationsThe price of 500mg*100 tablets per box may be more than 9,000 yuan (the price may fluctuate due to exchange rates). Mitotan generic drugs are also sold overseas, and their drug ingredients are basically the same as those of the original drug. For example, the specifications produced by Laos pharmaceutical factoriesThe price of 500mg*100 tablets per box may be more than 3,000 yuan (prices may fluctuate due to exchange rates).